Medical Research Institute

Alexandria 21648

0 studies enrolling now · 2 studies all time

What they study most

Mesothelioma, Neoplasms

Studies at this site

• An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol — Completed
• Nintedanib (BIBF 1120) in Mesothelioma — Stopped early